Evidence map›Paper›PMID 34570245›Full record

ArticleCellular and molecular life sciences : CMLS2021

Correction to: R-catcher, a potent molecular tool to unveil the arginylome.

Taewook Seo, Jihyo Kim, Ho-Chul Shin, Jung Gi Kim, Shinyeong Ju, Laxman Nawale, Goeun Han, Hye Seon Lee, Geul Bang, Jin Young Kim and 8 more

Abstract readPublished Erratum
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Taewook SeoAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Jihyo KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Ho-Chul ShinDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Jung Gi KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Shinyeong JuCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Laxman NawaleAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Goeun HanAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Hye Seon LeeDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Geul BangResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Jin Young KimResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Jeong Kyu BangDivision of Magnetic Resonance, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Kyung Ho LeeAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Nak-Kyun SoungAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Joonsung HwangAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Cheolju LeeCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Seung Jun KimDepartment of Biomolecular Science, KRIBB School, University of Science and Technology, Daejeon, 34113, Republic of Korea. ksj@kribb.re.kr.
Bo Yeon KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea. bykim@kribb.re.kr.
Hyunjoo Cha-MolstadAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea. hcha@kribb.re.kr.ORCID http://orcid.org/0000-0003-3676-7150

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34570245
PMCPMC9172863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.